Showing 611-620 of 1781 results for "".

• Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care

  https://reachmd.com/programs/cme/muscarinic-therapies-as-a-catalyst-for-change-addressing-clinical-inertia-in-schizophrenia-care/37101/
  Examine muscarinic modulation as an alternative to D2 antagonists for schizophrenia, with insights on dosing, tolerability, and patient selection. 
  • Text

• Preterm Labor and Progesterone

  https://reachmd.com/programs/advances-in-womens-health/preterm-labor-and-progesterone/1880/
  Preterm labor and delivery has an enormous impact on medical society and society in general. In fact, 12% of all deliveries in the United States occur before 37 weeks gestation, which makes preterm delivery the greatest contributor to neonatal morbidity and mortality. Dr. Alan Peaceman, Professor o
  • Audio
  • Podcast

• University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2

  https://reachmd.com/programs/grand-rounds-nation/university-of-arizona-preclinical-stage-alzheimers-disease-characterizing-and-defining-the-transition-between-normal-and-pathological-cognitive-aging-part-2/6407/
  For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in
  • Audio
  • Podcast

• University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1

  https://reachmd.com/programs/grand-rounds-nation/university-of-arizona-preclinical-stage-alzheimers-disease-characterizing-and-defining-the-transition-between-normal-and-pathological-cognitive-aging-part-1/6406/
  For people who carry genetic predispositions toward Alzheimer's disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in
  • Audio
  • Podcast

• University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3

  https://reachmd.com/programs/grand-rounds-nation/university-of-arizona-preclinical-stage-alzheimers-disease-characterizing-and-defining-the-transition-between-normal-and-pathological-cognitive-aging-part-3/6408/
  For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in
  • Audio
  • Podcast

• Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment

  https://reachmd.com/clinical-practice/optometry/Consensus-Panel-Highlights-Pharmacotherapy-for-Presbyopia-and-Considerations-for-the-Posterior-Segment/36580/
  This supplement summarizes a panel discussion among optometrists and retina specialists who convened to discuss the expanding armamentarium of presbyopia-correcting eye drops and establish a set of best practices regarding diagnostic testing, patient candidacy, and follow-up regimens.
  • Text

• The Heritage of Platelet-Derived Growth Factor

  https://reachmd.com/topics/regenerative-medicine/the-heritage-of-pdgf/48868/
  From its discovery nearly half a century ago to its current place in patient care and scientific conversation in aesthetic medicine, poorly healing skin wounds, orthopedics, and dental surgical reconstruction, platelet-derived growth factor (PDGF) stands as both a milestone of molecular biology and
  • Text

• Ins and Outs of Aesthetic Practice Planning

  https://reachmd.com/topics/practice-development/ins-and-outs-of-aesthetic-practice-planning/35208/
  Perspectives on getting started and getting out of aesthetic practice.
  • Text

• Passion for Practice in the Wake of the “Great Resignation”

  https://reachmd.com/topics/practice-development/passion-for-practice-in-the-wake-of-the-great-resignation/35150/
  As many aesthetic practices grapple with staff shortages and burnout, an expert emphasizes the opportunity to rebuild with purpose
  • Text

• Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates

  https://reachmd.com/programs/clinicians-roundtable/embedding-video-guidance-crc-reminders-fit-return-rates/56443/
  • Text

• Prev
• 1
• 2
• …
• 60
• 61
• 62
• 63
• 64
• …
• 178
• 179
• Next